Skip to main content

Revisional-RYGB Examined for GERD and Weight-Loss Failure

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Sept. 6, 2023 -- Following sleeve gastrectomy (SG), revisional Roux-Y-gastric-bypass (RYGB) is beneficial for remission of reflux symptoms and extra weight loss, according to a study published online Aug. 18 in Obesity Surgery.

Clément Destan, from Sorbonne Université in Paris, and colleagues conducted a retrospective study including consecutive patients undergoing R-RYGB for weight loss failure (WLF) or proton pump inhibitor (PPI) refractory gastroesophageal reflux disease (RGERD) after SG in bariatric care centers from 2012 to 2018.

The researchers found that 3.6 percent of the 720 patients underwent R-RYGB (54.4 percent for RGERD; 45.6 percent for WLF) within 44.8 ± 27.5 months post-SG. SG had enabled 27 ± 11.6 percent total weight loss (TWL) and 7.2 ± 12.5 percent TWL in the RGERD and WLF groups. Compared with RGERD-group patients, WLF-group patients had a higher body mass index and higher number of comorbidities at R-RYGB, while there was no difference between the groups in severe morbidity. At 12 months post-R-RYGB, percentage TWL was still higher in the RGERD group (35.6 ± 10.4 versus 23.8 ± 9.2 percent), but not after 24 months. In 94 and 97 percent of patients, R-RYGB corrected reflux symptoms and reduced PPI use, respectively. A similar prevalence of GERD at R-RYGB and a lower percent TWL at three years post R-RYGB were seen for those with a history of adjustable gastric banding (AGB) before SG.

"This study finds that R-RYGB after SG can efficiently and effectively correct RGERD and improve comorbidities, regardless of indication (i.e., RGERD or WLF)," the authors write. "However, patients should be carefully educated about the risks of revisional surgery, and about the fact that a previous history of AGB would likely limit the expected weight loss outcomes."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

Gastroesophageal Reflux Disease Increases Risk for Atrial Fibrillation

TUESDAY, July 2, 2024 -- Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2...

Small Differences in Weight Change With First-Line Antidepressants

MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.